| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 01/07/1998 | EP0815123A1 $g(b)-SHEET MIMETICS AND USE THEREOF AS PROTEASE INHIBITORS |
| 01/07/1998 | EP0815120A1 17-difluoromethylene-oestratrienes |
| 01/07/1998 | EP0815103A1 Trypsin and thrombin inhibitors |
| 01/07/1998 | EP0814814A1 Methods for the treatment of thrombosis |
| 01/07/1998 | EP0814802A2 Method of reducing prolonged coagulation time |
| 01/07/1998 | EP0814798A1 The pharmacological use of certain cystine derivatives |
| 01/07/1998 | EP0565396B1 1-[2-(arylsulfonylamino)-1-oxoethyl]piperidine derivatives, their preparation and use in therapy |
| 01/07/1998 | EP0486572B1 Improvements in granulocyte-macrophage colony-stimulating factor receptor and derivatives thereof |
| 01/07/1998 | CN1169284A Sodium alginate diester for preventing and curing thrombocytopenia and leukopenia |
| 01/07/1998 | CN1036934C Process for preparing isohirudins with improved stability |
| 01/06/1998 | US5705890 Platelet aggregation inhibitor, antithrombotic |
| 01/06/1998 | US5705625 Genetic engineering; medical diagnosis |
| 01/06/1998 | US5705606 Polypeptides for binding aggregation mediators such as fibrogen |
| 01/06/1998 | US5705523 Thromboxane a2 synthetase inhibitors |
| 01/06/1998 | US5705489 Having antithrombotic activity |
| 01/06/1998 | US5705486 Anticoagulants for blood disorders |
| 01/06/1998 | US5705198 Using phospholipid dependent prothrombin activator purified from snake venom |
| 12/31/1997 | WO1997049818A2 G-beta-gamma regulated phosphatidylinositol-3' kinase |
| 12/31/1997 | WO1997049809A1 Polypeptides capable of forming antigen binding structures with specificity for the rhesus d antigens, the dna encoding them and the process for their preparation and use |
| 12/31/1997 | WO1997049725A1 Modified factor viii |
| 12/31/1997 | WO1997049708A1 Tricyclic benzazepine vasopressin antagonists |
| 12/31/1997 | WO1997049707A1 Tricyclic benzazepine vasopressin antagonists |
| 12/31/1997 | WO1997049682A1 Fibrinogen receptor antagonists and medicinal preparations containing the same as the active ingredient |
| 12/31/1997 | WO1997049673A1 Selective thrombin inhibitors |
| 12/31/1997 | WO1997049404A1 Anticoagulant agents |
| 12/31/1997 | WO1997049286A1 Il-8 receptor antagonists |
| 12/31/1997 | CN1168886A Process for production of amidinobenzofuran and amidionbenzothiophen derivatives and salt thereof |
| 12/31/1997 | CN1168885A Process for prodn. of amidinoindole derivatives and salts thereof |
| 12/31/1997 | CA2258915A1 Anticoagulant agents |
| 12/31/1997 | CA2258885A1 Tricyclic benzazepine vasopressin antagonists |
| 12/30/1997 | US5703230 Meso-monoiodo-substituted tetramacrocyclic compounds and methods for making and using the same |
| 12/30/1997 | US5703208 3-amino-2-oxo-1-piperidineacetic derivatives as enzyme inhibitors |
| 12/30/1997 | US5703125 Substituted β-amino acid derivatives useful as platelet aggregation inhibitors |
| 12/30/1997 | US5703099 Treatment of thrombosis, arteriosclerosis, ischemic heart diseases, gastric ulcer or hypertension |
| 12/30/1997 | US5703050 Inhibit platelet aggregation, metastasis of carcinoma cells, osteoclast binding to bone surface |
| 12/30/1997 | US5702880 Aqueous solution comprising specified concentrations of potassium, sodium, magnesium, calcium and chloride ions, hydroxyethyl starch, glucose, lactate buffer |
| 12/29/1997 | EP0814164A2 A novel cDNA of direct-acting fibrinolytic serine protease |
| 12/29/1997 | EP0813598A1 Thrombin preparation |
| 12/29/1997 | EP0813525A1 Benzamidine derivatives their preparation and their use as anti-coagulants |
| 12/29/1997 | EP0813416A1 Reduction of infarct volume using citicoline |
| 12/24/1997 | WO1997048799A2 Polynucleotides from human fetal brain encoding secreted proteins |
| 12/24/1997 | WO1997042941A3 Buccal delivery system |
| 12/24/1997 | WO1997036497A3 Cocoa extract compounds and methods for making and using the same |
| 12/24/1997 | CN1168673A New dipeptide p-amidinobenzylamides with N-terminal sulfonyl or aminosulfonyl radicals |
| 12/24/1997 | CA2257847A1 Polynucleotides from human fetal brain encoding secreted proteins |
| 12/23/1997 | US5700911 Bone morphogenetic protein -11 (BMP-11) compositions |
| 12/23/1997 | US5700838 Hydroxamic acid derivatives as metalloproteinase inhibitors |
| 12/23/1997 | US5700832 Antianemic agent containing iron and difructose |
| 12/23/1997 | US5700816 Antiarthritic agents |
| 12/23/1997 | US5700815 Methods of increasing thrombomodulin expression |
| 12/23/1997 | US5700813 Treatment of thrombotic illness |
| 12/23/1997 | US5700812 Antispasmodic agent for cardiovascular disorder, antiserotonine agent |
| 12/23/1997 | US5700804 Inhibitors of plasminogen activator inhibitors |
| 12/23/1997 | US5700801 Antiinflammatory agents, bone disorders |
| 12/23/1997 | US5700796 Useful for treating congestive heart failure, disease conditions with excess renal water reabsorption and conditions with increased vasular resistance and coronary vasoconstriction |
| 12/23/1997 | US5700691 Culturing cd34+hematopoietic progenitor cells |
| 12/23/1997 | US5700677 Protein analogues of tissue plasminogen activator |
| 12/23/1997 | US5700664 For pharmaceutical preparations for stimulating cells involved in immune response and proper functioning of hematopoietioc system |
| 12/23/1997 | US5700663 Modified at one or more potential glycosylation sites or at the arginine 393 position |
| 12/23/1997 | CA2008391C 1,2-cyclohexylaminoaryl amides useful as analgesic agents |
| 12/18/1997 | WO1997047659A1 Synthetic polysaccharides, method for preparing same and pharmaceutical compositions containing said polysaccharides |
| 12/18/1997 | WO1997047618A1 Substituted imidazoles having cytokine inhibitory activity |
| 12/18/1997 | WO1997047312A1 Novel heparin binding peptides |
| 12/18/1997 | WO1997025052A3 Compositions comprising pvp having an average molecular weight in the range of 3,000 to 14,000 daltons |
| 12/18/1997 | CA2257614A1 Novel heparin binding peptides |
| 12/17/1997 | EP0812913A2 HR-1 receptor, a receptor of the cytokine receptors family |
| 12/17/1997 | EP0812844A2 Use of theophyllin derivatives for the treatment and prophylaxis fo shock conditions, novel xanthine compounds and processes for the production thereof |
| 12/17/1997 | EP0812330A2 Peptidyl compounds comprising an itim motif which regulate hematopoietic function and their use |
| 12/17/1997 | EP0812205A1 Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides |
| 12/17/1997 | EP0652750B1 Use of alpha,omega-dicarboxylic acids as fibrinogen reducers |
| 12/17/1997 | EP0651743B1 Indolinyl n-hydroxyurea and n-hydroxamic acid derivatives as lipoxygenase inhibitors |
| 12/17/1997 | EP0644762B1 Pyrazolopyridine compounds for the treatment of anemia |
| 12/17/1997 | EP0625908B1 Antidote for hirudin and synthetic thrombin inhibitors |
| 12/17/1997 | EP0515550B1 Heparin neutralization with platelet factor 4 |
| 12/17/1997 | CN1168156A Staphylokinase derivs. |
| 12/16/1997 | US5698677 Stable preparation for the treatment of blood coagulation disorders |
| 12/16/1997 | US5698552 Hetrazepinoid amides |
| 12/16/1997 | US5698536 Plasma-like substance |
| 12/11/1997 | WO1997046686A2 Tumor necrosis factor-related polypeptide |
| 12/11/1997 | WO1997046685A1 Polynucleotides encoding secreted proteins from human dendritic cells |
| 12/11/1997 | WO1997046683A2 Polynucleotides encoding secreted proteins |
| 12/11/1997 | WO1997046682A2 Polynucleotides from human adult pbmc encoding secreted proteins |
| 12/11/1997 | WO1997046577A1 New amino acid derivatives and their use as thrombin inhibitors |
| 12/11/1997 | WO1997046576A1 Anticoagulant peptidyl-arginine aldehyde derivatives |
| 12/11/1997 | WO1997046233A1 Use of raloxifene and of related compounds for the manufacture of a medicament for lowering plasma levels of lipoprotein(a) |
| 12/11/1997 | CA2256653A1 Use of raloxifene and of related compounds for the manufacture of a medicament for lowering plasma levels of lipoprotein(a) |
| 12/11/1997 | CA2256522A1 Polynucleotides encoding secreted proteins |
| 12/11/1997 | CA2256520A1 Polynucleotides encoding secreted proteins from human dendritic cells |
| 12/11/1997 | CA2256464A1 Tumor necrosis factor-related polypeptide |
| 12/11/1997 | CA2255625A1 New amino acid derivatives and their use as thrombin inhibitors |
| 12/10/1997 | EP0811616A1 Salts of 3-(2-(4-(4-(Amino-imino-methyl)-phenyl)-4-methyl-2,5-dioxo-imidazolidin-1-yl)-acetylamino)-3-phenyl-propionic acid ethylester |
| 12/10/1997 | EP0811610A1 Ortho-substituted benzoylguanidines process for their preparation, their use as medicament or diagnostic agent and medicaments containing them |
| 12/10/1997 | EP0811064A2 Mpl ligand analogs |
| 12/10/1997 | EP0811063A2 Chemokine receptors 88-2b ckr-3] and 88c and their antibodies |
| 12/10/1997 | EP0810994A1 Fibrinogen receptor antagonists |
| 12/10/1997 | EP0659193B1 Platelet aggregation inhibitors |
| 12/10/1997 | EP0610246B1 Novel thrombin-inhibiting protein from ticks |
| 12/10/1997 | CN1167484A Novel amidinonaphthyl derivative or salt thereof |
| 12/10/1997 | CN1036651C Method for prepn. of carbostyril derivatives |
| 12/09/1997 | US5696145 Vasopressin and oxytocin receptor |